AIFM2 and lung cancer: Koppula et al. identified that the anti-ferroptosis FSP1-Coenzyme Q10 axis is a major contributor to the radioresistance in KEAP1-inactivated lung cancer cells, a common lung cancer subtype with high risk of relapse and metastasis.